相关实验视频
Updated: Jan 13, 2026

08:34
Isolation of Atrial Myocytes from Adult Mice
Published on: July 25, 2019
11.4K
在心房EHT中,血清素的积极内效应:对心房表型的进一步证明?
Muhammed Sönmez1,2,3, Margaret Nandudu1,3, Paul Brunnbauer1,3
1University Medical Center Hamburg-Eppendorf, Institute of Experimental Pharmacology and Toxicology, Martinistraße 52, 20246, Hamburg, Germany.
Naunyn-Schmiedeberg's archives of pharmacology
|October 28, 2025
概括
人类诱导的多能干细胞衍生性心房心肌细胞 (hiPSC-aCM) 模仿人对血清素 (5-HT) 的心房反应. 这些hiPSC-aCM工程心脏组织 (EHT) 显示5-HT有选择性地增加电流和力,验证了它们在研究5-HT4受体中的用途.
科学领域:
- 心脏病学 心脏病学
- 干细胞生物学 干细胞生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 人类诱导的多能干细胞衍生心肌细胞 (hiPSC-CM) 是心脏研究的一个模型.
- 血清激素 (5-HT) 在人心中具有特定于心房的积极无otropic 作用.
- 根据5-HT反应区分心房和心室的hiPSC-CM是至关重要的.
研究的目的:
- 调查5-HT反应是否可以区分hiPSC-心房CM (hiPSC-aCM) 和hiPSC-心室CM (hiPSC-vCM).
- 评估hiPSC-aCM工程心脏组织 (EHTs) 作为研究人类心脏中5-HT4受体的模型.
主要方法:
- 使用网膜酸 (1μM) 或作为对照 (hiPSC-vCM) 使用hiPSC-CM分化为hiPSC-aCM.
- 测量了5-HT4受体 (HTR4) 表达的程度.
- 在EHT中评估了5-HT对电流 (ICa),力和作用电位持续时间 (APD) 的影响.
主要成果:
- 在hiPSC-aCM EHTs中,HTR4转录的丰度明显更高.
- 5-HT (100μM) 在hiPSC-aCM EHTs中增加了ICa和力,但在hiPSC-vCM EHTs中没有.
- 在hiPSC-aCM和hiPSC-vCMEHT中,5-HT也不同地影响了动作潜力的持续时间和击球率.
结论:
- hiPSC-aCM EHTs表现出心房选择性调节ICa和5-HT的力,反映了人类心脏生理学.
- 这些发现确立了hiPSC-aCM EHTs作为研究人类心脏中5-HT4受体功能的有价值模型.
更多相关视频
相关概念视频
Heart Failure Drugs: Inotropic Agents
1.2K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.2K
Electrophysiology of Normal Cardiac Rhythm
8.7K
The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase...
8.7K
Mechanism of Cardiac Arrhythmias
1.6K
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
1.6K
Conduction System of the Heart
12.5K
Autorhythmicity is a term that refers to the heart's inherent ability to generate electrical signals and instigate muscle contractions. This self-regulating conduction system within the heart consists of two key components: the pacemaker cells and specialized conducting cells.
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
12.5K
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
453
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
453
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
1.4K
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
1.4K

